| Application no. and date | 16151719.8 (espacenet) (Federated) (European Patent Register), 20110929 | | Patent/reg. no. and date | DK/EP 3040333, 20180912 | | Publication date | 20160706 | | Priority no. and date | US 388721 P, 20101001, US 201161494915 P, 20110609 | | EP pub. no. and date |
EP 3040333 20160706 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V1811-053-DK | | Inventor | CALIENNI, John Vincent, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
DE LA CRUZ, Marilyn, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
GONG, Baoqing, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
KARPINSKI, Piotr H., Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
LIU, Hui, 2 Blue Ridge Avenue
Green Brook, New Jersey 08812, US,
WAYKOLE, Liladhar Murlidhar, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
FLUBACHER, DIETMAR, Novartis Pharma AG
CH-4002 Basel, CH,
MICHEL, Pascal, Novartis Pharma AG
CH-4002 Basel, CH,
MOSE, Rasmus, Novartis Pharma AG
CH-4002 Basel, CH,
TESTA, Maria Caterina, Novartis Pharma AG
CH-4002 Basel, CH,
KAPA, Prasad Koteswara, Novartis Pharmaceuticals Corporation One Health
Plaza
East Hanover, New Jersey 07936, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/535 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Title | KRYSTALLINSKE FORMER AF 5-(2,6-DI-4-MORPHOLINYL-4-PYRIDMIDINYL)-4-TRIFLUORMETHYLPYRIDIN-2-AMIN, EN PIK3-HÆMMER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
